Max Portfolio Pct.
Check
Valuation
Check
Stock Quality:
Max Portfolio Pct.
Check
Valuation
Check
OPCH Price Action
Last 7 days
-2.4%
Last 30 days
14.6%
Last 90 days
5.2%
Trailing 12 Months
28.3%
OPCH Stock Price
OPCH RSI Chart
OPCH Valuation
OPCH Price/Sales (Trailing)
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
OPCH Fundamentals
OPCH Revenue
OPCH Earnings
OPCH Profitability
OPCH Investor Care
OPCH Alerts
Revenue & Growth
Revenue Breakdown
As of: Jun 30, 2025
Reportable
| |||||||||||
| |||||||||||
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 5.2B | 5.4B | 5.5B | 0 |
| 2024 | 4.4B | 4.6B | 4.8B | 5.0B |
| 2023 | 4.0B | 4.1B | 4.2B | 4.3B |
| 2022 | 3.6B | 3.7B | 3.8B | 3.9B |
| 2021 | 3.1B | 3.2B | 3.3B | 3.4B |
| 2020 | 2.5B | 2.8B | 2.9B | 3.0B |
| 2019 | 2.0B | 2.0B | 2.1B | 2.3B |
| 2018 | 1.1B | 1.3B | 1.6B | 1.9B |
| 2017 | 914.9M | 900.6M | 874.7M | 817.2M |
| 2016 | 976.3M | 961.9M | 939.2M | 935.6M |
| 2015 | 945.7M | 962.5M | 978.2M | 982.2M |
| 2014 | 809.8M | 867.6M | 908.4M | 922.7M |
| 2013 | 688.0M | 704.4M | 724.7M | 769.5M |
| 2012 | 579.3M | 603.6M | 640.2M | 662.6M |
| 2011 | 461.7M | 492.6M | 523.6M | 554.5M |
| 2010 | 1.3B | 1.4B | 1.5B | 430.7M |
| 2009 | 1.4B | 1.4B | 1.4B | 1.3B |
| 2008 | 1.2B | 1.3B | 1.4B | 1.4B |
| 2007 | 0 | 0 | 0 | 1.2B |
| 1997 | 0 | 0 | 0 | 0 |
Get all data in R, Python etc through our Historical Stock Data APIs
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
| CEO | Mr. John C. Rademacher |
|---|---|
| WEBSITE | optioncarehealth.com |
| SECTOR | Healthcare |
| INDUSTRY | Medical Care Facilities |
| EMPLOYEES | 5597 |
